Clinical Anesthesia Procedures of the Massachusetts General Hospital

Name: Clinical Anesthesia Procedures of the Massachusetts General Hospital
Price: 8330 ISK
Availability: InStock
Author: Keith H. Baker; Edward A. Bittner; Hovig V. Chitilian; Ryan J. Horvath; Wilton C. Levine; Jamie L. S
ISBN: 9781975243005

Höfundar: Keith H. Baker; Edward A. Bittner; Hovig V. Chitilian; Ryan J. Horvath; Wilton C. Levine; Jamie L. S (Útgáfa: 11)

Kaup valmöguleikar

Written by MGH Department of Anesthesia residents and attendings, and under the senior editorial leadership of Dr. Keith H. Baker, Clinical Anesthesia Procedures of the Massachusetts General Hospital, Eleventh Edition, emphasizes the clinical fundamentals necessary for the safe delivery of anesthesia and perioperative care in everyday practice. Organized into three convenient sections, Evaluating the Patient Before Anesthesia, Administration of Anesthesia, and Perioperative Issues, it presents information in concise outline format for quick reference.

Nánar um bókina

Útgefandi: Wolters Kluwer Health

ISBN: 9781975243005

Print ISBN: 9781975242985

Format: ePub

Útgáfa: 11

Höfundar: Keith H. Baker; Edward A. Bittner; Hovig V. Chitilian; Ryan J. Horvath; Wilton C. Levine; Jamie L. S

Tungumál: English

Útgefið: 2025-09-09

Prent takmörkun á líftíma: 10

Prent takmörkun: 2

Afritunar takmörkun: 2

Flokkar: Heilbrigðisvísindi

Efnisflokkar: Læknisfræði › Svæfingafræði

Kaflar

Cover
Title Page
Copyright
Contributors
Preface
Contents
PART I: EVALUATING THE PATIENT BEFORE ANESTHESIA
1 Evaluating the Patient Before Anesthesia
I. INTRODUCTION
II. HISTORY
III. REVIEW OF SYSTEMS
IV. THE PHYSICAL EXAMINATION
V. LABORATORY STUDIES
VI. PREOPERATIVE MEDICAL OPTIMIZATION
VII. ANESTHETIC ASSESSMENT AND PLAN
VIII. PATIENT DISCUSSION
IX. INFORMED CONSENT
X. DAY OF SURGERY PREMEDICATION
XI. DELAYING SURGICAL PROCEDURES
XII. ETHICAL CONSIDERATIONS IN PATIENT CARE
2 Basics of Echocardiography and Lung Ultrasound
INTRODUCTION
I. CARDIAC POINT-OF-CARE ULTRASOUND (POCUS)
II. CLINICAL USES OF POCUS
III. TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE)
IV. CARDIAC FUNCTION ASSESSMENT
V. Hemodynamic Measurements
VI. CARDIAC FILL STATUS ASSESSMENT
VII. Lung Ultrasound (LUS)
VIII. Conclusion
3 Specific Considerations for Cardiac Disease
I. GENERAL CONSIDERATIONS
II. CORONARY ANATOMY
III. PREOPERATIVE CARDIOVASCULAR EVALUATION FOR NONCARDIAC SURGERY
IV. PREANESTHETIC CONSIDERATIONS
V. ISCHEMIC HEART DISEASE
VI. VALVULAR HEART DISEASE
VII. CONGESTIVE HEART FAILURE
VIII. HYPERTROPHIC CARDIOMYOPATHY
IX. CONGENITAL HEART DISEASE
X. CARDIAC TRANSPLANT PATIENT
XI. CARDIAC IMPLANTABLE ELECTRONIC DEVICES: PACEMAKERS AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
4 Specific Considerations With Pulmonary Disease
I. OVERVIEW
II. PULMONARY FUNCTION
III. EFFECTS FROM SURGICAL PROCEDURE
IV. ASTHMA
V. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
VI. OBESITY
VII. ACUTE RESPIRATORY DISTRESS SYNDROME
VIII. OTHER PULMONARY CONDITIONS
5 Specific Considerations With Renal Disease
I. GENERAL CONSIDERATIONS
II. PHYSIOLOGY
III. RENAL FAILURE
IV. ANESTHETIC MANAGEMENT
V. PHARMACOLOGY AND THE KIDNEY
VI. PHARMACOLOGY AND RENAL FAILURE
VII. FUTURE CONSIDERATIONS FOR IDENTIFICATION OF PATIENTS AT RISK OF PERIOPERATIVE AKI
6 Specific Considerations With Liver Disease
I. ANATOMY, PHYSIOLOGY AND PATHOLOGY OF THE LIVER
II. ANESTHETIC CONSIDERATIONS IN PATIENTS WITH LIVER DISEASE
III. PHARMACOLOGY IN SEVERE LIVER DISEASE
IV. POSTOPERATIVE HEPATIC DYSFUNCTION
V. ANESTHETIC MANAGEMENT OF PATIENTS WITH LIVER DISEASE
VI. RISK ASSESSMENT AND CLASSIFICATION
VII. COMMON PROCEDURES IN PATIENTS WITH LIVER DISEASE
VIII. LIVER RESECTION
IX. METHODS TO REDUCE BLOOD LOSS IN LIVER RESECTION
X. LIVER TRANSPLANTATION
XI. ENHANCED RECOVERY AFTER SURGERY
7 Specific Considerations With Endocrine Disease
I. DIABETES MELLITUS
II. HYPOGLYCEMIA
III. THYROID DISEASE
IV. PARATHYROID DISEASE AND CALCIUM METABOLISM
V. ADRENAL CORTICAL DISEASE
VI. Adrenal medullary disease, pheochromocytoma, and paragangliomas
VII. ANTERIOR PITUITARY DISEASES
VIII. POSTERIOR PITUITARY DISEASES
IX. CARCINOID
8 Infectious Diseases and Infection Control in Anesthesia
I. INTRODUCTION
II. INFECTION CONTROL IN THE OR
III. PERIOPERATIVE ANTIBIOTICS
IV. PATHOGENIC ORGANISMS OF ANESTHETIC CONCERN
V. OCCUPATIONAL EXPOSURE TO INFECTIOUS DISEASE
VI. SPECIAL PATIENT POPULATIONS
PART II: ADMINISTRATION OF ANESTHESIA
9 Safety in Anesthesia
I. OVERVIEW OF SAFETY IN ANESTHESIA
II. STANDARDS FOR SAFE ANESTHESIA CARE
III. TYPES OF ERRORS
IV. GENERAL SAFETY STRATEGIES
V. QUALITY ASSURANCE AND SAFETY IMPROVEMENT PROGRAMS
10 The Anesthesia Machine
I. OVERVIEW
II. THE GAS DELIVERY SYSTEM (Figure 10.1)
III. BREATHING SYSTEMS
IV. ANESTHESIA VENTILATORS
V. SAFETY FEATURES
VI. SCAVENGING
VII. GAS ANALYSIS
VIII. ANESTHESIA MACHINE CHECKOUT RECOMMENDATIONS
11 Administration of General Anesthesia
I. INDICATIONS FOR GENERAL ANESTHESIA
II. PREOPERATIVE EVALUATION
III. INDUCTION OF GENERAL ANESTHESIA
IV. AIRWAY MANAGEMENT
V. MAINTENANCE OF ANESTHESIA
VI. EMERGENCE, EXTUBATION, AND TRANSPORT
VII. ADVERSE EFFECTS RELATED TO ANESTHESIA
12 Intravenous and Inhalation Anesthetics
I. PHARMACOLOGY OF INTRAVENOUS ANESTHETICS
II. PHARMACOLOGY OF INHALATION ANESTHETICS
13 Airway Evaluation and Management
I. APPLIED ANATOMY
II. EVALUATION
III. MASK AIRWAY
IV. LARYNGEAL MASK AIRWAY
V. ENDOTRACHEAL INTUBATION
VI. THE DIFFICULT AIRWAY AND EMERGENCY AIRWAY TECHNIQUES
VII. SPECIAL CONSIDERATIONS
14 Neuromuscular Blockade
I. NEUROMUSCULAR JUNCTION
II. GENERAL PHARMACOLOGY
III. NEUROMUSCULAR BLOCKADE
IV. MONITORING OF NEUROMUSCULAR FUNCTION
V. REVERSAL OF NMB
VI. EFFECTS OF NMB
VII. Disorders That Influence the Response to NMBDs
15 Monitoring
I. STANDARD MONITORING
II. CARDIOVASCULAR SYSTEM
III. CVP AND CARDIAC OUTPUT
IV. RESPIRATORY SYSTEM
V. TEMPERATURE MONITORING
16 Monitoring Anesthetic Brain States
I. GENERAL CONSIDERATIONS
II. ELECTROENCEPHALOGRAM-BASED INDICES OF LEVEL OF UNCONSCIOUSNESS
III. END-TIDAL ANESTHETIC CONCENTRATION
IV. THE SPECTRAL ANALYSIS OF THE EEG
V. EFFECTS OF DIFFERENT ANESTHETICS ON THE BRAIN
VI. AGE-RELATED CHANGES IN ANESTHETIC-INDUCED EEG SIGNATURES
VII. CLINICAL MONITORING OF ANESTHETIC STATES
VIII. CONCLUSION
17 Intra-anesthetic Problems
I. HYPOTENSION
II. HYPERTENSION
III. DYSRHYTHMIAS
IV. HYPOXEMIA
V. HYPERCARBIA
VI. ABNORMAL URINE OUTPUT
VII. HYPOTHERMIA
VIII. HYPERTHERMIA
IX. DIAPHORESIS (SWEATING)
X. LARYNGOSPASM
XI. BRONCHOSPASM
XII. ASPIRATION
XIII. PNEUMOTHORAX
XIV. MYOCARDIAL ISCHEMIA
XV. PULMONARY EMBOLISM
XVI. CARDIAC TAMPONADE
XVII. MALIGNANT HYPERTHERMIA
XVIII. ANAPHYLACTIC AND ANAPHYLACTOID REACTIONS
XIX. FIRE AND ELECTRICAL HAZARDS IN THE OPERATING ROOM
XX. EQUIPMENT MALFUNCTIONS
18 Perioperative Hemodynamic Control
I. BLOOD PRESSURE
II. AUTOREGULATION
III. ADRENERGIC RECEPTOR PHYSIOLOGY (Table 18.1)
IV. ADRENERGIC AGONISTS (Table 18.2)
V. NONADRENERGIC AGENTS
VI. β-ADRENERGIC ANTAGONISTS (Table 18.3)
VII. VASODILATORS (Table 18.4)
VIII. INDUCED HYPOTENSION
IX. DRUG DOSAGE CALCULATIONS
19 Local Anesthetics
I. GENERAL PRINCIPLES
II. CLINICAL USES OF LOCAL ANESTHETICS
III. TOXICITY
20 Spinal, Epidural, and Caudal Anesthesia
I. GENERAL CONSIDERATIONS
II. SEGMENTAL LEVEL REQUIRED FOR SURGERY
III. CONTRAINDICATIONS TO NEURAXIAL ANESTHESIA
IV. SPINAL ANESTHESIA
V. EPIDURAL ANESTHESIA
VI. COMBINED SPINAL–EPIDURAL ANESTHESIA
VII. CAUDAL ANESTHESIA
VII. ANTICOAGULATION AND NEURAXIAL BLOCKADE
21 Regional Anesthesia
ABBREVIATIONS
I. GENERAL CONSIDERATIONS
II. GENERAL CONTRAINDICATIONS
III. COMPLICATIONS COMMON TO ALL NERVE BLOCKS
IV. EQUIPMENT
V. NERVE LOCALIZATION TECHNIQUES
VI. REGIONAL ANESTHESIA OF THE NECK
VII. REGIONAL ANESTHESIA OF THE UPPER EXTREMITY
VIII. REGIONAL ANESTHESIA OF THE LOWER EXTREMITY
IX. REGIONAL ANESTHESIA OF THE TRUNK
22 Anesthesia for Orthopedic Surgery
I. GENERAL CONSIDERATION
II. ANESTHESIA FOR TOTAL HIP AND KNEE ARTHROPLASTY
III. ANESTHESIA FOR SHOULDER SURGERY
IV. ANESTHESIA FOR LOWER EXTREMITY SURGERY
V. ANESTHESIA FOR ELBOW, ARM, AND HAND SURGERY
VI. ANESTHESIA FOR ORTHOPEDIC ONCOLOGY
VII. ANESTHESIA FOR ORTHOPEDIC TRAUMA
VIII. ANESTHESIA FOR SPINE SURGERY
23 Anesthesia for Neurosurgery
I. PHYSIOLOGY
II. PHARMACOLOGY
III. ELECTROPHYSIOLOGIC MONITORING
IV. PREOPERATIVE CONSIDERATIONS FOR NEUROSURGICAL PROCEDURES
V. INTRAOPERATIVE MANAGEMENT
VI. SPECIFIC NEUROSURGICAL PROCEDURES
VII. SURGERY ON THE SPINE AND SPINAL CORD
24 Anesthesia for Spine Surgery
I. GENERAL CONSIDERATIONS
II. BLOOD LOSS
III. SPINAL CORD PERFUSION
IV. DISPOSITION
V. POSTOPERATIVE PAIN MANAGEMENT
25 Anesthesia for Transplant Surgery
I. HISTORY AND ETHICAL CONSIDERATIONS
II. ANESTHESIA FOR KIDNEY TRANSPLANTATION
III. ANESTHESIA FOR PANCREAS TRANSPLANTATION
IV. ANESTHESIA FOR LIVER TRANSPLANTATION
V. ANESTHESIA FOR ORGAN PROCUREMENT
26 Anesthesia for Abdominal Surgery
I. PREANESTHETIC CONSIDERATIONS
II. ANESTHETIC TECHNIQUES
III. MANAGEMENT OF ANESTHESIA
IV. ANESTHETIC CONSIDERATIONS FOR SPECIFIC ABDOMINAL TECHNIQUES AND PROCEDURES
27 Anesthesia for Thoracic Surgery
I. PREOPERATIVE EVALUATION AND PREPARATION
II. LUNG ISOLATION
III. ONE-LUNG VENTILATION
IV. DIAGNOSTIC PROCEDURES
V. PULMONARY RESECTION
VI. MEDIASTINAL MASS RESECTION
VII. ESOPHAGEAL SURGERY
VIII. TRACHEAL SURGERY
IX. LARYNGEAL SURGERY
X. INTERVENTIONAL PULMONARY PROCEDURES
XI. SPECIAL CIRCUMSTANCES
XII. INTRAOPERATIVE EXTRACORPOREAL LIFE SUPPORT
28 Anesthesia for Vascular Surgery
I. PREOPERATIVE ASSESSMENT AND MANAGEMENT
II. PERIPHERAL ARTERIAL SURGERY
III. CAROTID REVASCULARIZATION
IV. ABDOMINAL AORTIC REPAIR
V. THORACOABDOMINAL AORTIC ANEURYSM REPAIR
VI. AMPUTATIONS
VII. REGIONAL ANESTHESIA UNDER ANTICOAGULATION
VIII. GROIN ACCESS COMPLICATIONS
29 Anesthesia for Cardiac Surgery
I. CARDIOPULMONARY BYPASS
II. PREOPERATIVE ASSESSMENT FOR CARDIAC SURGERY
III. ANESTHETIC MANAGEMENT
IV. INDUCTION
V. POSTOPERATIVE CARE
VI. ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR CARDIAC SURGERY
VII. PEDIATRIC CARDIAC ANESTHESIA
VIII. OTHER CARDIAC PROCEDURES
IX. ANESTHESIA FOR “OFF-SITE” CARDIAC PROCEDURES
30 Anesthesia for Head and Neck Surgery
I. ANESTHESIA FOR OPHTHALMIC SURGERY
II. ANESTHESIA FOR OTORHINOLARYNGOLOGIC PROCEDURES
III. ANESTHESIA FOR PROCEDURES OF THE NECK
IV. ANESTHESIA FOR DENTISTRY AND ORAL AND MAXILLOFACIAL SURGERY
31 Anesthesia for Urologic Surgery
I. ANESTHESIA FOR SPECIFIC UROLOGIC PROCEDURES
II. LITHOTRIPSY
III. PATIENTS WITH SPINAL CORD PATHOLOGY
32 Anesthesia for Obstetrics and Gynecology
I. MATERNAL PHYSIOLOGY IN PREGNANCY (Table 32.1)
II. LABOR AND DELIVERY
III. MEDICATIONS COMMONLY USED FOR LABOR AND DELIVERY
IV. PLACENTAL TRANSFER OF DRUGS
V. ANALGESIA FOR LABOR AND VAGINAL DELIVERY
VI. ANESTHESIA FOR CESAREAN DELIVERY
VII. PREECLAMPSIA
VIII. PERIPARTUM HEMORRHAGE
IX. AMNIOTIC FLUID EMBOLISM
X. ANESTHESIA FOR NONOBSTETRIC SURGERY DURING PREGNANCY
XI. CPR DURING PREGNANCY
XII. ANESTHESIA FOR GYNECOLOGIC SURGERY
XIII. ANESTHESIA FOR OOCYTE RETRIEVAL
33 Anesthesia for Pediatric Surgery and Care of the Neonate
I. FETAL DEVELOPMENT
II. ANATOMY AND PHYSIOLOGY
III. THE PREANESTHETIC VISIT
IV. PERIPROCEDURAL CONSIDERATIONS AND FASTING GUIDELINES
V. PREPARATION OF THE OPERATING ROOM
VI. INDUCTION TECHNIQUES
VII. ENDOTRACHEAL INTUBATION
VIII. ANALGESIA
IX. PHARMACOTHERAPY
X. FLUID MANAGEMENT
XI. EMERGENCE AND POSTANESTHESIA CARE
XII. SPECIFIC PEDIATRIC ANESTHESIA PROBLEMS
34 Non-Operating Room Anesthesia
I. GENERAL CONSIDERATIONS
II. ANESTHESIA TECHNIQUES
III. CONTRAST MEDIA
IV. ANESTHESIA FOR DIAGNOSTIC RADIOLOGY
V. ANESTHESIA FOR CT-GUIDED THERMAL ABLATIONS
VI. ANESTHESIA FOR NEUROINTERVENTIONS
VII. ANESTHESIA FOR GASTROINTESTINAL, GENITOURINARY, AND VASCULAR RADIOLOGY PROCEDURES
VIII. ANESTHESIA FOR PROTON BEAM THERAPY AND RADIATION THERAPY
IX. ANESTHESIA FOR ELECTROCONVULSIVE THERAPY
X. ANESTHESIA FOR GASTROENTEROLOGY PROCEDURES
XI. ANESTHESIA FOR BRONCHOSCOPY PROCEDURES
XII. ANESTHESIA FOR NORA CARDIAC PROCEDURES
XIII. SAFETY IN NORA
35 Anesthesia for Trauma and Burns
I. INITIAL EVALUATION OF THE TRAUMA PATIENT
II. SPECIFIC INJURIES
III. THE PEDIATRIC TRAUMA PATIENT
IV. THE PREGNANT TRAUMA PATIENT
V. MAJOR BURN INJURIES
36 Transfusion Therapy
I. THE DECISION TO TRANSFUSE
II. COAGULATION STUDIES
III. BLOOD TYPING AND CROSS-MATCHING
IV. BLOOD COMPONENT THERAPY
V. PLASMA SUBSTITUTES
VI. PHARMACOLOGIC THERAPY
VII. CONSERVATION AND SALVAGE TECHNIQUES
VIII. COMPLICATIONS OF BLOOD TRANSFUSION THERAPY
IX. PERIOPERATIVE COAGULOPATHY
X. SPECIAL CONSIDERATIONS
PART III: PERIOPERATIVE ISSUES
37 The Postanesthesia Care Unit
I. GENERAL CONSIDERATIONS
II. ADMISSION TO THE PACU
III. MONITORING
IV. GENERAL COMPLICATIONS
V. EFFECTS OF ANESTHETICS AND SEDATIVES
VI. RESPIRATORY AND AIRWAY COMPLICATIONS
VII. HEMODYNAMIC AND CARDIOVASCULAR COMPLICATIONS
VIII. RENAL COMPLICATIONS
IX. NEUROLOGIC COMPLICATIONS
X. POSTOPERATIVE NAUSEA AND VOMITING
XI. PRINCIPLES OF PAIN MANAGEMENT
XII. BODY TEMPERATURE CHANGES
XIII. RECOVERY FROM REGIONAL AND NEURAXIAL ANESTHESIA
XIV. CRITERIA FOR DISCHARGE
XV. ENHANCED RECOVERY AFTER SURGERY
XVI. CONSIDERATIONS FOR PEDIATRIC RECOVERY
XVII. CRITICAL CARE IN THE POSTANESTHESIA RECOVERY UNIT
XVIII. PACU ROLE IN HOSPITAL CAPACITY CHALLENGES
XIX. PACU AS SURGE ICU CAPACITY IN PANDEMICS
38 Pain Management
I. DEFINITION AND TERMINOLOGY
II. TREATMENT OF ACUTE PAIN IN THE PERIOPERATIVE SETTING
III. MULTIMODAL ANALGESIA
IV. COMPLEMENTARY AND ALTERNATIVE MEDICINE IN PAIN MANAGEMENT
39 Adult, Pediatric, and Newborn Resuscitation
I. OVERVIEW
II. CARDIAC ARREST
III. ADULT RESUSCITATION
IV. PEDIATRIC RESUSCITATION
V. NEONATAL RESUSCITATION
40 Vascular Access
I. OVERVIEW
II. APPLIED VASCULAR ANATOMY
III. VASCULAR ACCESS DEVICES
IV. PRINCIPLES OF ULTRASOUND-GUIDED VASCULAR ACCESS
V. COMMON ISSUES AND TROUBLESHOOTING
Appendix I: Drugs With Narrow Therapeutic Ranges and Potential for Harm
Appendix II: Commonly Used Drugs
I. ACETAMINOPHEN
II. ADENOSINE
III. ALBUTEROL
IV. ALPROSTADIL (SEE APPENDIX I)
V. ALTEPLASE (SEE APPENDIX I)
VI. AMINOCAPROIC ACID (AMICAR)
VII. AMIODARONE
VIII. APREPITANT
IX. ARGATROBAN (SEE APPENDIX I)
X. ATENOLOL
XI. ATROPINE
XII. BICARBONATE, SODIUM (NaHCO3)
XIII. BIVALIRUDIN (SEE APPENDIX I)
XIV. CALCIUM CHLORIDE; CALCIUM GLUCONATE
XV. CARBOPROST (PROSTAGLANDIN F2α; HEMABATE)
XVI. CELECOXIB
XVII. CLEVIDIPINE (CLEVIPREX)
XVIII. CLOPIDOGREL (PLAVIX)
XIX. DANTROLENE
XX. DESMOPRESSIN ACETATE (DDAVP)
XXI. DEXAMETHASONE (DECADRON)
XXII. DILTIAZEM (CARDIZEM)
XXIII. DOBUTAMINE
XXIV. DOPAMINE
XXV. ENOXAPARIN (LOVENOX)
XXVI. EPHEDRINE
XXVII. EPINEPHRINE
XXVIII. EPOPROSTENOL (FLOLAN) (SEE APPENDIX I)
XXIX. EPTIFIBATIDE (INTEGRILIN) (SEE APPENDIX I)
XXX. ESMOLOL (BREVIBLOC)
XXXI. FLUMAZENIL (MAZICON)
XXXII. FOSPHENYTOIN
XXXIII. FUROSEMIDE (LASIX)
XXXIV. GLUCAGON
XXXV. GLYCOPYRROLATE
XXXVI. HALOPERIDOL (HALDOL)
XXXVII. HEPARIN—UNFRACTIONATED
XXXVIII. HYDRALAZINE
XXXIX. HYDROCORTISONE (SOLU-CORTEF)
XL. IPRATROPRIUM BROMIDE
XLI. ISOPROTERENOL
XLII. KETOROLAC (TORADOL)
XLIII. LABETALOL
XLIV. LEVETIRACETAM (KEPPRA)
XLV. LIDOCAINE (XYLOCAINE)
XLVI. LOW–MOLECULAR-WEIGHT HEPARIN
XLVII. MAGNESIUM SULFATE
XLVIII. MANNITOL
XLIX. METHYLENE BLUE
L. METHYLERGONOVINE (METHERGINE)
LI. METHYLPREDNISOLONE (SOLU-MEDROL)
LII. METOCLOPRAMIDE (REGLAN)
LIII. METOPROLOL (LOPRESSOR)
LIV. MILRINONE
LV. NALOXONE (NARCAN)
LVI. NICARDIPINE (CARDENE)
LVII. NITROGLYCERIN
LVIII. NITROPRUSSIDE (NIPRIDE)
LIX. NOREPINEPHRINE (LEVOPHED)
LX. OCTREOTIDE (SANDOSTATIN)
LXI. ONDANSETRON (ZOFRAN)
LXII. OXYTOCIN (PITOCIN)
LXIII. PHENOBARBITAL
LXIV. PHENOXYBENZAMINE
LXV. PHENYLEPHRINE
LXVI. PHENYTOIN (DILANTIN)
LXVII. PHOSPHORUS (SODIUM PHOSPHATE)
LXVIII. PHYSOSTIGMINE (ANTILIRIUM)
LXIX. POTASSIUM (KCL) (SEE APPENDIX I)
LXX. PROCHLORPERAZINE (COMPAZINE)
LXXI. PROMETHAZINE (PHENERGAN)
LXXII. PROPRANOLOL (INDERAL)
LXXIII. PROSTAGLANDIN E1 (ALPROSTADIL) (SEE APPENDIX I)
LXXIV. PROTAMINE
LXXV. RYANODEX (SEE DANTROLENE)
LXXVI. SCOPOLAMINE
LXXVII. TRANEXAMIC ACID
LXXVIII. VASOPRESSIN (ANTIDIURETIC HORMONE, PITRESSIN)
LXXIX. VERAPAMIL
LXXX. VITAMIN K (PHYTONADIONE)
LXXXI. WARFARIN (COUMADIN)
Appendix III: Common Intravenous Antibiotics
Index